Cargando…
Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
High-grade osteosarcoma (HGOS) is a very aggressive bone tumor which primarily affects adolescents and young adults. Although not advanced as is the case for other cancers, pharmacogenetic and pharmacogenomic studies applied to HGOS have been providing hope for an improved understanding of the biolo...
Autores principales: | Hattinger, Claudia Maria, Patrizio, Maria Pia, Luppi, Silvia, Serra, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369799/ https://www.ncbi.nlm.nih.gov/pubmed/32629971 http://dx.doi.org/10.3390/ijms21134659 |
Ejemplares similares
-
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing
por: Hattinger, Claudia Maria, et al.
Publicado: (2022) -
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021) -
Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments
por: Fanelli, Marilù, et al.
Publicado: (2020) -
Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine
por: Campion, Deirdre P., et al.
Publicado: (2019) -
Pharmacogenetics, pharmacogenomics and airway disease
por: Hall, Ian P
Publicado: (2002)